Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 14113
Country/Region: Malawi
Year: 2016
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $4,400,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $331,800
Care: TB/HIV (HVTB) $422,360
Care: Pediatric Care and Support (PDCS) $43,400
Laboratory Infrastructure (HLAB) $55,000
Health Systems Strengthening (OHSS) $60,500
Testing: HIV Testing and Counseling (HVCT) $255,200
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $301,260
Treatment: Adult Treatment (HTXS) $2,491,490
Treatment: Pediatric Treatment (PDTX) $438,990
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HRH_PRE By Graduates: Nurses 2017 45
HRH_PRE Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre 2017 45
HRH_PRE Sum of Graduates disaggregates 2017 45
HTS_TST Age/sex: <1 2017 17,743
HTS_TST Age/sex: 1-9 2017 141,624
HTS_TST Age/sex: 10-14 Female 2017 30,846
HTS_TST Age/sex: 10-14 Male 2017 29,915
HTS_TST Age/sex: 15-19 Female 2017 25,796
HTS_TST Age/sex: 15-19 Male 2017 24,694
HTS_TST Age/sex: 20-24 Female 2017 21,664
HTS_TST Age/sex: 20-24 Male 2017 20,531
HTS_TST Age/sex: 25-49 Female 2017 62,597
HTS_TST Age/sex: 25-49 Male 2017 58,593
HTS_TST Age/sex: 50+ Female 2017 21,630
HTS_TST Age/sex: 50+ Male 2017 18,786
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 110,090
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 110,039
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 131,688
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 122,602
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 474,419
HTS_TST Service Delivery Point (Facility): Inpatient 2017 30,833
HTS_TST Service Delivery Point (Facility): Other PITC 2017 134,736
HTS_TST Service Delivery Point (Facility): Pediatric 2017 83,969
HTS_TST Service Delivery Point (Facility): PMTCT 2017 134,736
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 4,272
HTS_TST Service Delivery Point (Facility): VCT 2017 85,873
HTS_TST Sum of Age/Sex disaggregates 2017 315,052
HTS_TST Sum of Aggregated Age/Sex <15 2017 220,129
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 254,290
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 474,419
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 500
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 485
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 1,511
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 1,447
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 1,270
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 1,207
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 3,668
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 3,429
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 1,269
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 1,101
HTS_TST_POS Test Result by Age: Positive: <1 2017 285
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 2,288
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 1,779
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 1,779
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 7,713
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 7,183
PMTCT_ART Already on ART at beginning of current pregnancy 2017 3,482
PMTCT_ART New on ART 2017 3,210
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 95,247
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 1,810
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 3,076
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 93
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 52
PMTCT_EID Sum of Infant Age disaggregates 2017 4,886
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 268
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 20,120
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 31,914
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 31,914
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 11,031
PMTCT_STAT By: Known positives at entry 2017 3,823
PMTCT_STAT By: Number of new positives identified 2017 3,258
PMTCT_STAT Number of new ANC and L&D clients 2017 100,819
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 95,247
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 805
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 3
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 1,285
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 1,286
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 444
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 2
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 689
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 1,090
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 1,101
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 376
PMTCT_STAT Sum of Positives Status disaggregates 2017 7,081
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 287
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 21,295
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 33,786
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 33,775
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 11,676
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 61
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 937
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 35
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 514
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,706
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,547
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 54,408
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 4,912
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 44,509
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 4,987
TB_SCREENDX Screen Result: Screened Positive for TB 2017 744
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 44,882
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 24,794
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 3,058
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 1,688
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 74,422
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 149
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2,229
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 80
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,229
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 3,687
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 3,933
TX_CURR Age/Sex: <1 2017 1,392
TX_CURR Age/Sex: <1-9 2017 6,093
TX_CURR Age/Sex: 10-14 Female 2017 1,402
TX_CURR Age/Sex: 10-14 Male 2017 1,275
TX_CURR Age/Sex: 15-19 Female 2017 2,582
TX_CURR Age/Sex: 15-19 Male 2017 550
TX_CURR Age/Sex: 20-24 Female 2017 8,122
TX_CURR Age/Sex: 20-24 Male 2017 922
TX_CURR Age/Sex: 25-49 Female 2017 32,683
TX_CURR Age/Sex: 25-49 Male 2017 17,320
TX_CURR Age/Sex: 50+ Female 2017 2,604
TX_CURR Age/Sex: 50+ Male 2017 3,400
TX_CURR Aggregated Age/Sex: <15 Female 2017 5,230
TX_CURR Aggregated Age/Sex: <15 Male 2017 4,930
TX_CURR Aggregated Age/Sex: 15+ Female 2017 42,642
TX_CURR Aggregated Age/Sex: 15+ Male 2017 25,543
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 78,345
TX_CURR Sum of age/sex disaggregates 2017 3,132
TX_CURR Sum of Aggregated Age/Sex <15 2017 10,160
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 68,185
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 78,345
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 1,295
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 1,223
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 7,866
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 4,369
TX_NEW By Age/Sex: <1 2017 346
TX_NEW By Age/Sex: 1-9 2017 1,508
TX_NEW By Age/Sex: 10-14 Female 2017 348
TX_NEW By Age/Sex: 10-14 Male 2017 316
TX_NEW By Age/Sex: 15-19 Female 2017 446
TX_NEW By Age/Sex: 15-19 Male 2017 89
TX_NEW By Age/Sex: 20-24 Female 2017 1,387
TX_NEW By Age/Sex: 20-24 Male 2017 153
TX_NEW By Age/Sex: 25-49 Female 2017 5,600
TX_NEW By Age/Sex: 25-49 Male 2017 3,532
TX_NEW By Age/Sex: 50+ Female 2017 448
TX_NEW By Age/Sex: 50+ Male 2017 580
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 14,753
TX_NEW Sum of Age/Sex disaggregates 2017 12,899
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 14,753
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 27,417
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 24,679
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 1,143
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1,078
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 14,442
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 8,016
TX_PVLS Numerator: Indication: Routine 2017 22,210
TX_PVLS Numerator: Indication: Targeted 2017 7
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,271
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 1,197
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 16,042
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 8,907
TX_PVLS_den Denominator: Indication: Routine 2017 24,679
TX_PVLS_den Denominator: Indication: Targeted 2017 8
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 147
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 644
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 147
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 136
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 444
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 95
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,416
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 163
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5,725
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,606
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 451
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 593
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 553
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 524
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8,033
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,457
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 13,567
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 14,921
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 164
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 708
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 165
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 148
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 498
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 108
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,561
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 173
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6,262
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,973
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 508
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 653
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 608
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 571
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8,839
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,903
Cross Cutting Budget Categories and Known Amounts Total: $270,000
Human Resources for Health $270,000